KianBehbakhtMD

PubMed

• The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma.
  Ahmadian, M., Post, M., Wolsky, R., Rickert, C., Jordan, K., Hu, J., Richer, J., Marjon, N., Sikora, M., Bitler, B., Clauset, A., Van Kleunen, L., Behbakht, K.> ;Biorxiv. 2024 Jan 29
• 6 citations
  ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.
  Alexandra McMellen, Tomomi M Yamamoto, Lubna Qamar, Brooke E Sanders, Lily L Nguyen, Daniela Ortiz Chavez, Jaidev Bapat, Amber Berning, Miriam D Post, Joshua Johnson, ...> ;Molecular Cancer Research. 2023 Jan 3
• 2 citations
  Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors.
  Tomomi M Yamamoto, Patricia G Webb, Dana M Davis, Heidi K Baumgartner, Elizabeth R Woodruff, Saketh R Guntupalli, Margaret Neville, Kian Behbakht, Benjamin G Bitler> ;Molecular Cancer Therapeutics. 2022 Apr 1
• 6 citations
  Impact of blinding interviewers to written applications on ranking of Gynecologic Oncology fellowship applicants from groups underrepresented in medicine.
  Jennifer Haag, Brooke E Sanders, Joseph Walker Keach, Carolyn Lefkowits, Jeanelle Sheeder, Kian Behbakht> ;Gynecologic Oncology Reports. 2022 Feb 1
• 1 citations
  Decoding the dynamic tumor microenvironment.
  Aaron Clauset, Kian Behbakht, Benjamin G. Bitler> ;Science Advances. 2021 Jun 4
• 303 citations
  Ovarian cancer, version 2.2020
  Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Andrew Berchuck, Lee-may Chen, Mihaela C. Cristea, Maria DeRosa, Eric L...> ;Journal of the National Comprehensive Cancer Network. 2021 Feb 2
• 13 citations
  PARPi after PARPi in epithelial ovarian cancer.
  K.G. Essel, Kian Behbakht, Tiffany S. Lai, L. Hand, E. Evans, Justin D. Dvorak, Kai Ding, Gottfried E. Konecny, Kathleen N. Moore> ;Gynecologic Oncology Reports. 2018 Jun 1
• 9 citations
  Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.
  Bradley R. Corr, Marisa R. Moroney, Jeanelle Sheeder, S. Gail Eckhardt, Brandon T. Sawyer, Kian Behbakht, Jennifer R. Diamond> ;Cancer. 2020 Oct 1
• 23 citations
  The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval.
  Kimberly R. Jordan, Matthew J. Sikora, Jill E. Slansky, Angela Minic, Jennifer K. Richer, Marisa R. Moroney, Junxiao Hu, Rebecca J. Wolsky, Zachary L. Watson, Tomomi M...> ;Clinical Cancer Research. 2020 Sep 14
• 4 citations
  Vulvar sarcoma outcomes by histologic subtype: a Surveillance, Epidemiology, and End Results (SEER) database review
  Sarah Johnson, Malte Renz, Lindsay J. Wheeler, Elisabeth Diver, Oliver Dorigo, Babak Litkouhi, Kian Behbakht, Brooke E. Howitt, Amer Karam> ;International Journal of Gynecological Cancer. 2020 Jul 7
• 55 citations
  Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Ran...
  Saketh R. Guntupalli, Alyse Brennecke, Kian Behbakht, Anna Tayebnejad, Christopher Breed, Lisa Marie Babayan, Georgina Cheng, Amin A. Ramzan, Lindsay J. Wheeler, Bradl...> ;JAMA Network Open. 2020 Jun 1
• 52 citations
  Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression
  Brandon T. Sawyer, Lubna Qamar, Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, Jennifer K. Richer, Kian Behbakht, Isabel R. Schlaepfer, Benjamin G. Bitler> ;Molecular Cancer Research. 2020 Mar 20
• 1 citations
  Spontaneous dichorionic-diamniotic twins in a noncommunicating uterine horn: A case report.
  Megan E. Ross, Stephen Scott, Kian Behbakht, Teresa Harper> ;Case Reports in Women's Health. 2020 Jan 30
• 46 citations
  Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
  Zachary L. Watson, Tomomi M. Yamamoto, Alexandra McMellen, Hyunmin Kim, Connor J. Hughes, Lindsay J. Wheeler, Miriam D. Post, Kian Behbakht, Benjamin G. Bitler> ;Clinical Epigenetics. 2019 Nov 27
• 16 citations
  A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, f...
  Roisin E. O'Cearbhaill, Wei Deng, Lee-may Chen, Joseph A. Lucci, Kian Behbakht, Nick M. Spirtos, Carolyn Y. Muller, Benedict B. Benigno, Matthew A. Powell, Emily Berry...> ;Gynecologic Oncology. 2019 Dec 1
• 20 citations
  Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations
  Pyoung Hwa Park, Tomomi M. Yamamoto, Hua Li, Allen L. Alcivar, Bing Xia, Yifan Wang, Andrea J. Bernhardy, Kristen M. Turner, Andrew V. Kossenkov, Zachary L. Watson, Ki...> ;Molecular Cancer Therapeutics. 2020 Feb 1
• 56 citations
  Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
  Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, Jennifer Aguilera, Rebecca Ferguson, Elmar Nurmemmedov, Tanay Thakar, George Lucian Moldovan, Hyunmin Kim, D...> ;Molecular Carcinogenesis. 2019 Oct 1
• 170 citations
  NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
  Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Andrew Berchuck, Jonathan S. Berek, Lee-may Chen, Mihaela C. Cristea, M...> ;Journal of the National Comprehensive Cancer Network. 2019 Aug 1
• 26 citations
  Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.
  Amin A. Ramzan, Benjamin G. Bitler, Douglas A. Hicks, Kelsey Barner, Lubna Qamar, Kian Behbakht, Theresa L. Powell, Thomas Jansson, Heidi Wilson> ;Molecular and Cellular Biochemistry. 2019 Jul 10
• 9 citations
  Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma
  Crystal L. Adams, Irina Dimitrova, Miriam D. Post, Lacey Gibson, Monique A. Spillman, Kian Behbakht, Andrew P. Bradford> ;Experimental and Molecular Pathology. 2019 Jul 10
• 49 citations
  Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers
  Marisa R. Moroney, Kurtis D. Davies, Adam C Wilberger, Jeanelle Sheeder, Miriam D. Post, Amber A. Berning, Christine M. Fisher, Carolyn Lefkowits, Saketh R. Guntupalli...> ;Gynecologic Oncology. 2019 Jun 1
• 15 citations
  Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel
  Christopher Breed, Douglas A. Hicks, Patricia G. Webb, Carly E. Galimanis, Benjamin G. Bitler, Kian Behbakht, Heidi K. Baumgartner> ;Molecular Cancer Research. 2019 Jan 3
• 58 citations
  Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
  Gerald Steven Falchook, Robert L. Coleman, Andrzej Roszak, Kian Behbakht, Ursula A. Matulonis, Isabelle Ray-Coquard, Piotr Sawrycki, Linda R. Duska, William P. Tew, Sh...> ;JAMA Oncology. 2019 Jan 1
• 50 citations
  CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
  Lindsay J. Wheeler, Zachary L. Watson, Lubna Qamar, Tomomi M. Yamamoto, Miriam D. Post, Amber A. Berning, Monique A. Spillman, Kian Behbakht, Benjamin G. Bitler> ;Oncogenesis. 2018 Nov 26
• 3 citations
  Society of Gynecologic Oncology 2018 Annual Meeting on Women's Cancer: Meeting report
  J. Alejandro Rauh-Hain, Kian Behbakht, Wendy R. Brewster> ;Gynecologic Oncology. 2018 Nov 1
• Join now to see all

Journal Articles

• CBX2 Identified as Driver of Anoikis Escape and Dissemination in High Grade Serous Ovarian Cancer  
  Monique A Spillman, Kian Behbakht, Miriam D Post, Amber A Berning, Nature
• Minority Race Predicts Treatment by Non-Gynecologic Oncologists in Women with Gynecologic Cancer  
  Saketh R Guntupalli, Amin A Ramzan, Kian Behbakht, Bradley R Corr, Annals of Surgical Oncology